RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 98 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,773,000 | -64.0% | 909,258 | 0.0% | 1.59% | -55.5% |
| Q1 2022 | $10,475,000 | +15.4% | 909,258 | 0.0% | 3.58% | +82.6% |
| Q4 2021 | $9,074,000 | -23.6% | 909,258 | 0.0% | 1.96% | -28.7% |
| Q3 2021 | $11,875,000 | -33.3% | 909,258 | 0.0% | 2.75% | -16.9% |
| Q2 2021 | $17,803,000 | -7.9% | 909,258 | 0.0% | 3.31% | -11.4% |
| Q1 2021 | $19,340,000 | -65.9% | 909,258 | -52.4% | 3.74% | -53.5% |
| Q4 2020 | $56,762,000 | +37.2% | 1,909,258 | 0.0% | 8.03% | +4.1% |
| Q3 2020 | $41,374,000 | -2.8% | 1,909,258 | 0.0% | 7.72% | -39.1% |
| Q2 2020 | $42,576,000 | +18.6% | 1,909,258 | -19.1% | 12.67% | -42.0% |
| Q1 2020 | $35,911,000 | -34.7% | 2,359,463 | -1.4% | 21.85% | -9.7% |
| Q4 2019 | $54,955,000 | -17.2% | 2,393,497 | -22.2% | 24.19% | -14.9% |
| Q3 2019 | $66,387,000 | -1.9% | 3,074,893 | 0.0% | 28.41% | +3.9% |
| Q2 2019 | $67,648,000 | -19.7% | 3,074,893 | 0.0% | 27.34% | -21.3% |
| Q1 2019 | $84,283,000 | +2.0% | 3,074,893 | 0.0% | 34.75% | -50.3% |
| Q4 2018 | $82,653,000 | -7.9% | 3,074,893 | 0.0% | 69.94% | +15.2% |
| Q3 2018 | $89,695,000 | -6.7% | 3,074,893 | 0.0% | 60.73% | +63.1% |
| Q2 2018 | $96,121,000 | +79.1% | 3,074,893 | +14.0% | 37.23% | +80.2% |
| Q1 2018 | $53,658,000 | -31.5% | 2,696,392 | 0.0% | 20.67% | -34.2% |
| Q4 2017 | $78,357,000 | – | 2,696,392 | – | 31.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |